Dark
Streaming/Mobile
OldĀ Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:42:29 EDT Tue 15 Jul 2025
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:MIRM
- MIRUM PHARMACEUTICALS INC -
https://mirumpharma.com/
16:42:29 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
MIRM
- Q
1.7
50.97
·
53.01
3.2
51.98
-1.30
-2.4
313.3
15,972
5,403
53.46
53.46
51.725
54.234 36.21
16:20:00
Jul 10
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Up
-- UPC Restricted:
No
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 5403
More trades...
Time ET
Ex
Price
Change
Volume
16:20:00
Q
51.98
-1.30
9
16:13:19
Q
51.48
-1.80
17
16:04:14
Q
51.98
-1.30
1
16:04:12
Q
51.98
-1.30
1
16:04:12
Q
51.98
-1.30
1
16:04:03
Q
51.98
-1.30
1
16:04:02
Q
51.98
-1.30
1
16:02:27
Q
51.98
-1.30
209
16:02:26
Q
51.98
-1.30
268
16:02:16
Q
51.98
-1.30
1,053
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2025-07-10 18:15
U:MIRM
News Release
200
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-06-10 20:40
U:MIRM
News Release
200
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-05-19 08:30
U:MIRM
News Release
200
Mirum Pharmaceuticals Appoints Doug Sheehy, JD, as Chief Legal Officer
2025-05-14 16:05
U:MIRM
News Release
200
Mirum Pharmaceuticals to Participate in Upcoming Investor Conferences
2025-05-09 18:00
U:MIRM
News Release
200
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-05-09 08:30
U:MIRM
News Release
200
Volixibat Data from Mirum's VANTAGE PBC Study Showcased at EASL
2025-05-07 16:01
U:MIRM
News Release
200
Mirum Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
2025-04-30 08:30
U:MIRM
News Release
200
Mirum Pharmaceuticals to Announce First Quarter 2025 Financial Results and Host Conference Call on May 7, 2025
2025-04-28 08:30
U:MIRM
News Release
200
Mirum Pharmaceuticals to Present Data at Upcoming Medical Congresses
2025-04-14 08:30
U:MIRM
News Release
200
Mirum's LIVMARLI Now FDA Approved in Tablet Formulation
2025-04-10 19:00
U:MIRM
News Release
200
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-03-27 08:30
U:MIRM
News Release
200
LIVMARLI Now Approved in Japan for ALGS and PFIC
2025-03-10 20:00
U:MIRM
News Release
200
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-02-26 16:01
U:MIRM
News Release
200
Mirum Pharmaceuticals Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Update
2025-02-24 08:30
U:MIRM
News Release
200
Mirum's CTEXLI(TM) (chenodiol) Tablets Receives FDA Approval for Treatment of Cerebrotendinous Xanthomatosis (CTX)
2025-02-19 16:04
U:MIRM
News Release
200
Mirum Pharmaceuticals to Announce Fourth Quarter and Year-End 2024 Financial Results and Host Conference Call on February 26, 2025
2025-02-10 19:00
U:MIRM
News Release
200
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-01-13 08:30
U:MIRM
News Release
200
Mirum Pharmaceuticals Announces Preliminary Unaudited 2024 Net Product Sales and Cash Balance and Provides Corporate Updates
2025-01-10 18:30
U:MIRM
News Release
200
Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2025-01-06 16:04
U:MIRM
News Release
200
Mirum Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference